Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065347 · ClinicalTrials.gov registry record
Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 84
- Enrollment target
NCT04065347: Completed study, sponsored by University of Colorado, Denver.
NCT04065347 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04065347 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
This study is being done to evaluate the relationship between adherence to antiretroviral therapy (ART) and HIV drug concentrations in persons living with HIV (PLWH) that are taking tenofovir alafenamide (TAF). Adherence will be measured with an ingestible biosensor (digital pill). Antiretroviral drug concentrations will be measured in different types of blood cells.
Primary Outcome
Steady-state drug concentration distribution and quantiles for highly adherent (i.e. \>95% of ingestions) participants.
Interventions
- DEVICE Digital Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-11-21 |
| Est. Completion | 2023-05-16 |
What the finished NCT04065347 record still lists
NCT04065347 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Digital Pill is the first listed.
NCT04065347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04065347 about?
NCT04065347 is a clinical study titled "Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)". This study is being done to evaluate the relationship between adherence to antiretroviral therapy (ART) and HIV drug concentrations in persons living with HIV (PLWH) that are taking tenofovir alafenamide (TAF). Adherence will be measured with an ingestible biosensor (digital pill). Antiretroviral dr...
What is the current status of trial NCT04065347?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2019-11-21. Estimated completion is 2023-05-16.
What interventions are being tested in trial NCT04065347?
The interventions under investigation include: Digital Pill (DEVICE).
Who is sponsoring clinical trial NCT04065347?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI